Waldenström's macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated CA-125

Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):54-59. doi: 10.1016/j.hemonc.2017.02.004. Epub 2017 Mar 31.

Abstract

Waldenström's macroglobulinemia is a rare hematology malignancy which often presents with "B symptoms," anemia, and thrombocytopenia. A 46-year-old woman presented with 2 months of abdominal distension accompanied by an unintentional 20-lb weight loss. Her abdominal CT scan demonstrated diffuse carcinomatosis with bilateral ovarian lesions and screening labs revealed a markedly elevated CA-125, suggesting a diagnosis of ovarian cancer. Upon admission for workup, patient was found to have a significant protein gap, later attributed to a markedly elevated IgM. Omental and bone marrow biopsy confirmed the diagnosis of Waldenström's macroglobulinemia, with elevation in CA-125 thought to be secondary to peritoneal irritation. This patient has since been successfully treated with six cycles of bendamusine and rituximab with no evidence of disease on staging scans and normalization of both CA-125 and IgM. To our knowledge, this is the first documented case of Waldenström's macroglobulinemia presenting with symptoms classically associated with ovarian cancer and demonstrates the importance of maintaining a broad differential when evaluating patients with abdominal carcinomatosis.

Keywords: CA-125; Ovarian cancer; Waldenström’s macroglobulinemia.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Ascites* / diagnosis
  • Ascites* / drug therapy
  • Ascites* / metabolism
  • Ascites* / pathology
  • Bendamustine Hydrochloride / administration & dosage
  • CA-125 Antigen / metabolism*
  • Female
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology
  • Peritoneal Neoplasms* / diagnosis
  • Peritoneal Neoplasms* / drug therapy
  • Peritoneal Neoplasms* / metabolism
  • Peritoneal Neoplasms* / pathology
  • Rituximab / administration & dosage
  • Waldenstrom Macroglobulinemia* / diagnosis
  • Waldenstrom Macroglobulinemia* / drug therapy
  • Waldenstrom Macroglobulinemia* / metabolism
  • Waldenstrom Macroglobulinemia* / pathology

Substances

  • CA-125 Antigen
  • Rituximab
  • Bendamustine Hydrochloride